Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Factors to Consider The Zacks Consensus Estimate for Guardant's total revenues is pegged at around $151 million, while the same for earnings is pegged at a loss of 72 cents per share. Both metrics indicate improvements over the year-ago quarter's levels. Through its screening business, Guardant intends to provide critical insights into what drives oncology disease. The company derives its revenues from two sources — precision oncology testing and development services and other revenue. The company generates the majority of its revenue from its precision oncology testing business, which consists of the sale of the company's tests to its clinical and biopharmaceutical customers. The Zacks Consensus Estimate for precision oncology testing revenues is pegged at $139 million, likely driven by an increase in clinical and biopharmaceutical testing volume. The Zacks Consensus Estimate for total tests performed (both clinical and biopharma customers) stands at around 55,493. The dev
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week [Yahoo! Finance]Yahoo! Finance
- Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease WeekBusiness Wire
- Rafay Announces New Platform-as-a-Service Capabilities for GPU-based Workloads, Empowering Customers to Quickly Leverage the Power of AI [Yahoo! Finance]Yahoo! Finance
- Triomics Automates Oncology Workflows With GenAI Powered Platform, Raises $15M [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 5/9/24 - Beat
GH
Sec Filings
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- 5/16/24 - Form 4
- GH's page on the SEC website